Perspectives
Clinical Thinking,
Shared Openly
How we evaluate evidence, make decisions, and navigate the boundary between what medicine knows and what it doesn't — yet.
Perspectives
How we evaluate evidence, make decisions, and navigate the boundary between what medicine knows and what it doesn't — yet.
The 2026 ACC/AHA lipid guidelines rewrote the rules on cholesterol management. LDL targets are back. ApoB and Lp(a) are no longer optional. And imaging has a clearer role than ever.
Read →
Functional, integrative, precision, longevity. There are too many names for this kind of medicine, and most of them don't help patients nearly as much as they think they do.
Read →
VO₂ max is the single strongest predictor of longevity in the medical literature. Stronger than smoking, hypertension, and coronary artery disease. Almost no one measures it.
Read →
A Cochrane review of 250,000 participants found annual physicals don't reduce mortality. Here's what the standard visit misses, what the evidence says you should be measuring instead, and why the format is the problem.
Read →
A member texted at 9pm: "What about peptides?" Here's what we told her — and what the evidence actually says about BPC-157, GHK-Cu, and the difference between promising and proven.
Read →